期刊文献+

肠道病毒71型中和抗体检测用标准病毒候选株的筛选及制备 被引量:10

Screening and preparation of candidate standard strain for determination of neutralizing antibody against enterovirus 71
原文传递
导出
摘要 目的筛选并制备肠道病毒71型(Enterovirus 71,EV71)中和抗体检测用标准病毒候选株,规范EV71中和抗体检测方法。方法通过对亲本株与非亲本株交叉中和试验,进行相应的几何平均滴度(GMT)比较,从10株EV71毒株中筛选出具有理想亲本中和能力、又具有较广泛交叉中和作用的毒株。筛选出的毒株按《中国药典》三部(2010版)相关要求,冷冻干燥后制备1批符合我国疾病流行特征的标准病毒候选株,联合3家实验室对候选株的病毒滴度进行协作标定,并初步应用于人血清样品的检测。结果筛选出交叉中和能力强、分离、传代背景清晰的EV71 V03株(523-07T)作为候选病毒株;制备的候选病毒株分装精确度、水分含量、无菌检查、支原体检查、其他外源因子检查等项目均符合《中国药典》三部(2010版)相关要求;经联合标定,候选毒株的平均病毒滴度为4.83 lgTCID50/ml(95%CI:4.53~5.12 lgTCID50/ml),变异系数为3.16%;应用候选毒株和中和抗体定值标准品检测EV71自然感染人血清样品,可将实验室间检测差异由4.4倍降至1.6倍。结论初步筛选出的候选株EV71/523-07T株具有理想的亲本株中和作用,又具有较广泛的交叉中和特性,有望成为EV71中和抗体检测的标准毒株候选株。 Objective To screen and prepare the candidate standard strain to standardize the method for determination of neutralizing antibody against enterovirus71(EV71).Methods One virus strain with strong neutralizing capability to parent strain and cross-neutralizing capability to non-parent strains was screened from ten EV71 stains by cross-neutralization test in which the GMTs of parent and non-parent strains were compared.According to requirements in Chinese Pharmacopoeia(Volume Ⅲ,2010 edition),one batch of candidate standard EV71 strain with the epidemic characteristics in China was prepared by lyophilization,cooperatively calibrated for titer by three independent laboratories,and preliminarily applied to determination of human serum samples.Results EV71 / V03(523-07T) strain with homogeneous cross-neutralizing capability and clear background of isolation and subculture was screened,of which the precision of filling,moisture content,as well as the results of sterility test,mycoplasma test and examination on adventitious agents met the requirements in Chinese Pharmacopoeia(Volume Ⅲ,2010 edition).The titer of the candidate strain was 4.83 lgTCID50 / ml(95%CI: 4.53-5.12 lgTCID50 / ml),with a coefficient of variation of 3.16%.By combined application of the candidate strain and quantitation standard for EV71 neutralizing antibody,the difference between determination results of human serum samples naturally infected with EV71 in various laboratories decreased from 4.4 folds to 1.6 folds.Conclusion The screened candidate strain EV71 / V03(523-07T),with satisfactory neutralizing capability to parent strain and cross-neutralizing capability to various non-parent strains,might be used as a candidate standard strain for determination of neutralizing antibody against EV71.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第6期725-729,共5页 Chinese Journal of Biologicals
基金 国家科技支撑计划(2008BAI69B01) 国家科技重大专项课题(2009ZX10004-804)
关键词 肠道病毒A型 手足口病 中和抗体 Enterovirus A,Human Hand-foot-and-mouth disease(HFMD) Neutralizing antibody
  • 相关文献

参考文献4

二级参考文献81

  • 1董晓楠,应剑,陈应华.1970~2004年全球肠道病毒71型分离株的分子流行病学分析[J].科学通报,2007,52(9):1021-1027. 被引量:108
  • 2Schmidt NJ,Lennette EH,Ho HH.An apparently new enterovirus isolated from patients with disease of the central nervous system.J Infect Dis,1974,129(3):304-309.
  • 3Herrero LJ,Lee CS,Hurrelbrink RJ,et al.Molecular epidemiology of enterovirus 71 in penisular Malaysia,1997 -2000.Arch Virol,2003,148(7):1369-1385.
  • 4Wang JR,Tuan YC,Tsai liP,et al.Change of major genotype of entcrovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000.J Clin Microbiol,2002,40 (1):10-15.
  • 5Scotto-Lavino E,Du G,Frohman MA.3' end eDNA amplification using classic RACE.Nat Pro'toe,2006,1 (6):2742-2745.
  • 6Scotto-Lavino E,Du G,Frohman MA.5' end cDNAamplification using classic RACE.Nat Protoc,2006,1 (6):2555-2562.
  • 7Brown BA,Oberste MS,Alexander JP Jr,et al.Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998.J Virol,1999,73(12):9969-9975.
  • 8Yoke-Fun C,AbuBakar S.Phylogenetie evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes.BMC Microbiol,2006,6:74.
  • 9Lin KR,Hwang KP,Ke GM,et al.Evolution of EV71 genogroup in Taiwan from 1998 to 2005:an emerging of subgenogroup C4 of EV71.J Med Virol,2006,78(2):254-262.
  • 10Cardosa M J,Perera D,Brown BA,et al.Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region:comparative analysis of the VP1 and VP4 genes.Emerg Infect Dis,2003,9(4):461-468.

共引文献82

同被引文献52

  • 1田波,段海生,荣一兵,周世力.肠道病毒71型分子流行病学研究进展[J].中国病毒学,2004,19(4):426-429. 被引量:90
  • 2中国疾病预防控制中心.法定传染病报告[EB/OL].(2013-03-27)[2013-10-12].http://www.chinacdc.cn/tjsj/fdcrbbg/.
  • 3Dong C, Wang J, Liu L, et al. Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenieity in rhesus monkeys [J]. Hum Vaccine, 2010, 6 (12): 1028-1037.
  • 4Liu L, Zhang Y, Wang J, et al. Study of the integrated im mune response induced by an inactivated EV71 vaccine [J]. PLoSOne, 2013, 8 (1): e54451.
  • 5Bek EJ, Hussain KM, Phuektes P, et al. Formalin inactiva ted vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection [J]. Vaccine, 2011, 29 (29/30); 4829-4838.
  • 6Arita M, Nagata N, Iwata N, et al. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spec- trum of antigenieity with attenuated neurovirulence in cyno molgusmonkeys[J].J Virol, 2007, 81 (17): 9386- 9395.
  • 7Sun S, Jiang L, Liang Z, et al. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Cox- saekievirus A16 infection in newborn mice [J]. Hum Vaecin Immunother, 2014:e29823.
  • 8Chung CY, Chen CY, Lin SY, etal. Enterovirus 71 virus like particle vaccine: improved production conditions for en- hanced yield [J]. Vaccine, 2010, 28 (43) :6951-6957.
  • 9Foo DG, Alonso S, Chow VT, et al. Passive protection a- gainst lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide [J]. Microbes Infect, 2007, 9 (11): 1299-1306.
  • 10Liu JN, Wang W, Duo JY, et al. Combined peptides of hu- man enterovirus 71 protect against virus infection in mice [J]. Vaccine, 2010, 28 (46) :7444-7451.

引证文献10

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部